Ollete, Rogelio L.
HRN: 22-49-87 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/20/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/20/2023
01/27/2023
IV
500mg
Q8H
S/P Exlap For Perforated Gastric Ulcer Disease
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes